Acchrom Tech, providing overall solutions for products and technical services in the field of chromatography, will complete the layout of life science instruments and products and increase investment in R&D with the fresh proceeds.
Acchrom Tech (Chinese: 华谱科仪) announced its completion of the Angel financing round worth CNY 100 million (USD 14.45 million) recently. The round was led by BioTrack Capital (Chinese: 博远资本), with the participation from CDBI Partners (Chinese: 辰德资本) and SDIC Unity Capital (Chinese: 国投创合). Changhai Capital (Chinese: 长海资本) is the exclusive financial advisor for this round.
The funds will be used to improve the company's capacity to provide clients with overall chromatography solutions.
Founded in 2015, Acchrom Tech is one of the few high-end Chinese chromatography brands that can break the monopoly of foreign brands and realize the closed loop of chromatography equipment, consumables, software and services. The company has established a rich product matrix for high-performance liquid chromatography (HPLC) and Ultra-high performance liquid chromatography (UHPLC). Besides, it has a full range of detectors to meet clients'needs.
After many years of development, Acchrom Tech established a complete chromatography column, software and application service system, and formed a whole product ecological chain with the instrument. Moreover, the company developed a series of columns for different scenarios, such as pharmaceutical and life science analysis, which have excellent performance in separation and stability.
The company's competitors include Wufeng Scientific Instrument (Chinese: 伍丰仪器), Dalian Elite (Chinese: 大连依利特) and Chengdu Corui (Chinese: 成都珂睿).